英傑電氣(300820.SZ):截止到目前,核聚變相關業務規模在公司整體業務中佔比仍然較小
格隆匯5月27日丨英傑電氣(300820.SZ)在互動平臺表示,公司多年來一直積極爲國內科研院所的重要項目提供電源配套服務,其中涵蓋了包括核聚變等核電領域的相關業務。公司直接參與這些項目所需設備的電源配套,爲相關實驗裝置提供關鍵的電源設備支持。但之前配套的項目基本都處於科研院所實驗階段。截止到目前,核聚變相關業務規模在公司整體業務中佔比仍然較小,尚未對公司業績產生顯著影響。公司已留意到近期核聚變業務板塊呈現的積極動向,後續將持續跟蹤該領域動態、深入挖掘相關信息,努力爭取把握業務機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.